148 related articles for article (PubMed ID: 19399678)
21. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
[TBL] [Abstract][Full Text] [Related]
22. Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):293-9. PubMed ID: 12909246
[TBL] [Abstract][Full Text] [Related]
23. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
Kager M; Spruss T; Schneider MR; von Angerer E
J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
[TBL] [Abstract][Full Text] [Related]
24. Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.
White DA; Zhang Z; Li L; Gerberich J; Stojadinovic S; Peschke P; Mason RP
Cancer Lett; 2016 Sep; 380(1):69-77. PubMed ID: 27267808
[TBL] [Abstract][Full Text] [Related]
25. Response of the R3327-AT1 Dunning prostate tumor to fast neutrons and cobalt-60.
Hahn EW; Wolber G; Bak M; Hoever KH; Gerlach L; Volm M; Lorenz WJ
Strahlenther Onkol; 1989 Apr; 165(4):283-5. PubMed ID: 2711333
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
27. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland.
Borghede G; Hedelin H; Holmäng S; Johansson KA; Sernbo G; Mercke C
Radiother Oncol; 1997 Sep; 44(3):245-50. PubMed ID: 9380823
[TBL] [Abstract][Full Text] [Related]
28. Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat.
Peschke P; Karger CP; Scholz M; Debus J; Huber PE
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):239-46. PubMed ID: 20934276
[TBL] [Abstract][Full Text] [Related]
29. Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor.
Zhao D; Constantinescu A; Chang CH; Hahn EW; Mason RP
Radiat Res; 2003 May; 159(5):621-31. PubMed ID: 12710873
[TBL] [Abstract][Full Text] [Related]
30. The influence of brachytherapy dose heterogeneity on estimates of alpha/beta for prostate cancer.
Lindsay PE; Moiseenko VV; Van Dyk J; Battista JJ
Phys Med Biol; 2003 Feb; 48(4):507-22. PubMed ID: 12630745
[TBL] [Abstract][Full Text] [Related]
31. Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors.
Glowa C; Karger CP; Brons S; Zhao D; Mason RP; Huber PE; Debus J; Peschke P
Cancer Lett; 2016 Aug; 378(2):97-103. PubMed ID: 27224892
[TBL] [Abstract][Full Text] [Related]
32. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
33. Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor.
Bourke VA; Zhao D; Gilio J; Chang CH; Jiang L; Hahn EW; Mason RP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1179-86. PubMed ID: 17336219
[TBL] [Abstract][Full Text] [Related]
34. Mathematical modeling of tumor response to radiation: radio-sensitivity correlation with BOLD, TOLD, ΔR1 and ΔR2* investigated in large Dunning R3327-AT1 rat prostate tumors.
Belfatto A; White DA; Zhang Z; Zhang Z; Cerveri P; Baroni G; Mason RP
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():3266-9. PubMed ID: 26736989
[TBL] [Abstract][Full Text] [Related]
35. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.
Joon DL; Hasegawa M; Sikes C; Khoo VS; Terry NH; Zagars GK; Meistrich ML; Pollack A
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1071-7. PubMed ID: 9276374
[TBL] [Abstract][Full Text] [Related]
36. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
37. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays.
Elgqvist J; Timmermand OV; Larsson E; Strand SE
Anticancer Res; 2016 Jan; 36(1):103-9. PubMed ID: 26722033
[TBL] [Abstract][Full Text] [Related]
39. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.
Nahum AE; Movsas B; Horwitz EM; Stobbe CC; Chapman JD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):391-401. PubMed ID: 12957250
[TBL] [Abstract][Full Text] [Related]
40. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R
J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
